Microba Life Sciences Ltd

Microba Investor Hub - Webinars

Microba Investor Hub

Microba Investor Hub - Corporate Governance

Microba Investor Hub - Shareholder Information

Corporate

Microba Investor Hub - News & Media

Microba Investor Hub - Announcements

DM Sans

Australian Financial Review

upload.jpg

Gut health business Microba is seeking $30 million via an initial public offering and has secured a heavyweight American investor. Microba has developed a kit that allows users to perform a test of their gut microbiome. Microba and its brokers Bell Potter and Canaccord Genuity launched a non deal roadshow on Tuesday, telling investors the book was scheduled to close early next week, ahead of a March ASX listing.

Australian Financial Review | Microba reboots IPO; secures Bill-Gates backed cornerstone investor